NanoRepro AG/€NN6
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About NanoRepro AG
NanoRepro AG, headquartered in Marburg, Germany, specializes in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests and food supplements for both home and professional use. The company's product portfolio includes tests for family planning, preventive healthcare, allergies, and infectious diseases, with a focus on self-diagnostics that provide quick results on-site. Founded in 2006, NanoRepro has been publicly listed since October 2008. The company collaborates with institutions such as the University of Marburg and the Research Center for Medical Engineering and Biotechnology to ensure high-quality product development. NanoRepro's strategic positioning emphasizes flexibility in product design, in-depth market understanding, and just-in-time manufacturing practices to optimize manufacturing costs. ([nanorepro.com](https://www.nanorepro.com/en/company/overview?utm_source=openai), [nanorepro.com](https://www.nanorepro.com/en/company/development?utm_source=openai))
Ticker
€NN6
Sector
Primary listing
XETRA
Industry
Health Care Equipment & Supplies
Headquarters
Employees
22
ISIN
DE0006577109
Website
NanoRepro AG Metrics
BasicAdvanced
€19M
-
-€0.25
-2.99
-
Price and volume
Market cap
€19M
Beta
-2.99
52-week high
€1.80
52-week low
€1.17
Financial strength
Current ratio
74.419
Quick ratio
62.328
Profitability
EBITDA (TTM)
-4.787
Gross margin (TTM)
66.07%
Net profit margin (TTM)
-89.81%
Operating margin (TTM)
-134.96%
Effective tax rate (TTM)
18.03%
Revenue per employee (TTM)
€160,000
Management effectiveness
Return on assets (TTM)
-7.17%
Return on equity (TTM)
-7.82%
Valuation
Price to revenue (TTM)
5.41
Price to book
0.49
Price to tangible book (TTM)
0.53
Growth
Revenue change (TTM)
-74.98%
Earnings per share change (TTM)
-50.35%
3-year revenue growth (CAGR)
-70.21%
10-year revenue growth (CAGR)
23.59%
3-year earnings per share growth (CAGR)
-50.68%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for NanoRepro AG stock?
NanoRepro AG (NN6) has a market cap of €19M as of July 02, 2025.
What is the P/E ratio for NanoRepro AG stock?
The price to earnings (P/E) ratio for NanoRepro AG (NN6) stock is 0 as of July 02, 2025.
Does NanoRepro AG stock pay dividends?
No, NanoRepro AG (NN6) stock does not pay dividends to its shareholders as of July 02, 2025.
When is the next NanoRepro AG dividend payment date?
NanoRepro AG (NN6) stock does not pay dividends to its shareholders.
What is the beta indicator for NanoRepro AG?
NanoRepro AG (NN6) has a beta rating of -2.99. This means that it has an inverse relation to market volatility.